Not defending NV, or trying to "pump" the stock - the only way for success here is if the technology actually works - which at this points we have no idea what is really happening.
Why would anyone pay $5.5M to Adaptive for nothing? And, why would the University of Cambridge get involved with the research?
If NV goes out of business, Propp probably takes all.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.